Senseonics Holdings, Inc. is a company in the U.S. stock market and it is a holding in 30 U.S.-traded ETFs. SENS has around 29.7M shares in the U.S. ETF market.
Similarly, What sector is SENS in?
Key Data
| Label | Value |
|---|---|
| Exchange | AMEX |
| Sector | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| 1 Year Target | $3.00 |
What does SENS company do? Senseonics Holdings, Inc. is a medical technology company. The Company is focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community.
Thereof, How many shares does SENS have?
Share Statistics
| Avg Vol (3 month) 3 | 13.61M |
|---|---|
| Shares Outstanding 5 | 463.15M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 333.03M |
| % Held by Insiders 1 | 9.91% |
What is SENS news?
Stock Exchange News Service (SENS)
The JSE offers a service that provides the user with access to company announcements such as mergers, take-overs, rights offers, capital issues, cautionaries – all of which have a direct impact on the movement in the market. This service is called Stock Exchange news Service.
When did Senseonics go public?
In connection with the offering, the common stock of Senseonics Holdings, Inc. has been approved for listing on the NYSE MKT. Trading is scheduled to commence on the NYSE MKT on Friday, March 18, 2016 under the symbol « SENS. »
What is Sens news?
Stock Exchange News Service (SENS)
The JSE offers a service that provides the user with access to company announcements such as mergers, take-overs, rights offers, capital issues, cautionaries – all of which have a direct impact on the movement in the market. This service is called Stock Exchange news Service.
What are Senseonics holdings?
Senseonics Holdings, Inc. operates as a medical technology company. The Company focuses on the design, development, and commercialization of glucose monitoring systems.
What institutions are buying NIO?
Largest shareholders include Baillie Gifford & Co, BlackRock Inc., Vanguard Group Inc, State Street Corp, VWIGX – Vanguard International Growth Fund Investor Shares, Susquehanna International Group, Llp, Goldman Sachs Group Inc, Citadel Advisors Llc, VEIEX – Vanguard Emerging Markets Stock Index Fund Investor Shares, …
Who owns the most Sens stock?
Top 10 Owners of Senseonics Holdings Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| BlackRock Fund Advisors | 6.29% | 28,066,063 |
| The Vanguard Group, Inc. | 4.27% | 19,025,222 |
| SSgA Funds Management, Inc. | 2.56% | 11,425,321 |
| Masters Capital Management LLC | 1.57% | 7,000,000 |
Is Sens a shorted stock?
Short Shares Availability
This table shows the number of shares of US:SENS available to be shorted at a leading prime brokerage. It is not the total number of shares available to short, nor is it the short interest.
What does Sens stand for?
SENS
| Acronym | Definition |
|---|---|
| SENS | Strategies for Engineered Negligible Senescence |
| SENS | Stock Exchange News Service (Johannesburg Stock Exchange; South Africa) |
| SENS | System Event Notification Service |
| SENS | Structural Engineering System |
Will Senseonics get FDA approval?
Continuous glucose monitoring system maker Senseonics has won FDA approval for its Eversense E3, which can be used to measure glucose levels in adults with diabetes for up to six months. The system works using a sensor that is implanted just under the skin by a healthcare provider.
How does Eversense CGM work?
The sensor is inserted under the skin (upper arm) and measures glucose in interstitial fluid for up to 90 days. These glucose levels are then calculated by the smart transmitter and sent to the app. The Eversense Sensor lasts up to 90 days.
What is a CGM transmitter?
Continuous glucose monitoring (CGM) devices help you manage Type 1 or Type 2 diabetes with fewer fingerstick tests. A sensor just under your skin measures your glucose levels 24 hours a day. A transmitter sends results to a wearable device or cell phone.
Who owns the most stock in NIO?
Top 10 Owners of NIO Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| BlackRock Fund Advisors | 2.99% | 40,093,147 |
| The Vanguard Group, Inc. | 2.76% | 36,994,474 |
| SSgA Funds Management, Inc. | 2.45% | 32,887,731 |
| Goldman Sachs & Co. LLC (Private … | 1.73% | 23,202,778 |
What hedge funds are buying NIO?
NIO (NYSE:NIO) Institutional Buying and Selling
| Reporting Date | Hedge Fund | Ownership in Company |
|---|---|---|
| 3/9/2022 | Norges Bank | 0.864% |
| 2/25/2022 | Garde Capital Inc. | 0.000% |
| 2/23/2022 | Resources Investment Advisors LLC. | 0.001% |
| 2/23/2022 | BlackRock Inc. | 4.081% |
Did BlackRock buy NIO stock?
2022-02-10 – BlackRock Inc. has filed a 13F-HR form disclosing ownership of 64,036,975 shares of Nio Inc (US:NIO) with total holdings valued at $2,028,693,000 USD as of 2021-12-31.
What companies own Sens stock?
Top 10 Owners of Sesen Bio Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| SSgA Funds Management, Inc. | 2.15% | 4,286,758 |
| Northern Trust Investments, Inc.(… | 0.90% | 1,797,262 |
| Group One Trading LP | 0.39% | 786,075 |
| Citadel Advisors LLC | 0.34% | 686,500 |
Who owns Sensonic?
Strong partners, firmly established company values, an exciting corporate history and distinct characteristics: Get to know Sensonic – the youngest company of the Frauscher Group!
What is Fintel io?
What is Fintel? Fintel.IO is a platform that provides advanced research tools for investors looking to find an edge on the market through quantitative data analysis. At its very core, Fintel.IO is a stock screener that provides specific information to investors normally used by institutional investors and hedge funds.
Join TheMoney.co community and don’t forget to share this post !
